Chung Shih

Title: Innovations of Chung Shih

Introduction

Chung Shih is an accomplished inventor based in Lawrence, KS (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. With a total of 2 patents, his work has the potential to impact medical treatments significantly.

Latest Patents

Chung Shih's latest patents include a bioerodible implant that offers a controlled release dosage form. This invention comprises a polymer formed by condensing beneficial agents with hydroxyl functionality of two or more with diketene acetals or divinyl ethers. This polymer delivers beneficial agents to a biological environment of use, with a statistically significant portion of the beneficial agent covalently bonded within the polymer matrix. Another notable patent is for novel prodrugs of methyldopa, which are [(alkoxycarbonyl)oxy]alkyl esters of methyldopa. These compounds, along with pharmaceutical compositions containing them, liberate methyldopa upon administration to warm-blooded animals, along with innocuous side products.

Career Highlights

Chung Shih is currently associated with Merck & Company, Inc., a leading global healthcare company. His work at Merck has allowed him to focus on innovative solutions that address critical health challenges.

Collaborations

Some of his notable coworkers include Gaylen M Zentner and Randall V Sparer, who have collaborated with him on various projects within the pharmaceutical domain.

Conclusion

Chung Shih's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work continues to pave the way for new treatment options that can improve patient outcomes.